The Case for Waiving Intellectual Property Protection for Covid-19 Vaccines
The arrival of vaccines against Covid-19 gives hope in ending the pandemic that has claimed close to 2.84 million lives so far. However, inoculating millions of people all over the world would require the massive production of vaccines, followed by their equitable distribution. An impediment to production and distribution of vaccines is the intellectual property (IP) rights that their developers enjoy. India and South Africa have together propo